Sanofi India's Stock Hits 52-Week Low, Underperforms Market Amidst Bearish Trend

Sanofi India, a leading pharmaceutical company in India, has been facing a downward trend in its stock performance. On June 13, 2024, the company's stock lost -41.7%, hitting a new 52-week low of Rs. 5850.55. This underperformance has led to a 'Hold' call by MarketsMOJO. The stock has been on a consecutive fall for the last two days, with a significant decline of -41.77% in this period. It opened with a gap down of -41.7% today and touched an intraday low of Rs. 5850.55. The stock has been trading at this price since then, with no significant range. Sanofi India's stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. In comparison, the Sensex has shown a positive performance of 0.34% in the last 1 day and 5.62% in the last 1 month, while Sanofi India has underperformed with -35.10% and -18.79% returns, respectively. It is important to note that this article is based on factual information and does not include any external data or sources. It is not intended to provide any recommendations or predictions about the future potential of Sanofi India's stock. As a largecap company in the pharma industry, Sanofi India's stock performance is closely monitored by investors and analysts.